The global traumatic brain injury market is estimated to be worth USD 2.90 billion by 2029 from USD 1.88 billion in 2024, growing at a CAGR of 9.12% from 2024 to 2029.
A traumatic brain injury is an injury inflicted on the brain either deeply, like breaking the skull and penetration through the brain tissue, or superficial injuries, like bruises and torn tissues in the brain. Brain injury can occur for various reasons, like accidents, bullet injuries, a rod to the head, a hit in the back of the head, etc. A brain injury can cause disruptions in both psychomotor, i.e., physical, and psychological functions of a person. The symptoms of a brain injury are physical, sensory, cognitive, and behavioral, like dizziness, headaches, loss of consciousness, blurred vision, bad taste in the mouth, speech problems, etc. A severe brain injury can cause seizures, convolutions, lack of coordination, back out for hours, confusion, etc. Therefore, a traumatic brain injury needs immediate medical attention and care. Traumatic brain injuries now have more treatment options than before, and the market is being explored on a broader horizon with new research and critical players.
Additionally, growing awareness regarding the cognitive and physical ill repercussions of traumatic brain injuries supports the expansion of the market. Furthermore, with more government support and funds for research studies and emerging key market participants, the rising adoption of newer technologies for overcoming and reciprocating traumatic brain injuries fuel the market. The rise in the common causes for traumatic brain injuries, such as accidents, sports injuries, military injuries, domestic violence, crimes, falls, etc., further accelerates the growth of the traumatic brain injury market.
The rising cases of TBI incidents worldwide are fuelling the growth of this market. For instance, according to the NIH (National Library of Medicine), Around 1.7 million Americans get traumatic brain injuries, with seniors 65 and older and teenagers between the ages of 15 and 19 having the highest risk of suffering one. According to the Centers for Disease Control and Prevention (CDC) statistics, around 1.5 million Americans yearly recover from traumatic brain injuries (TBI). Approximately 230,000 of them are hospitalized. It is predicted that 69 million (95% CI 64-74 million) people worldwide experience TBI annually, with Southeast Asia and the Western Pacific facing the highest illness burden. In low-income countries, head injuries after traffic accidents are more prevalent, and these nations also have the highest TBIs secondary to traffic accidents. However, the most considerable estimated incidence of TBI is seen in North America and Europe, which have better statistics. In children aged 14 and under, falls were the primary cause of more than half (55%) of TBIs, while in older adults aged 65 and over, falls were the primary cause of more than two-thirds (81%) of all reported TBIs. Sports- and recreation-related TBIs are thought to occur in the United States annually in the range of 1.6 million to 3.8 million. The most common cause of traumatic brain injury (TBI) in young people (ages 15 to 24) globally, particularly in low-income populations, is motor vehicle accidents. Men are more likely than women to require hospitalization and are almost three times as likely to pass away from a TBI.
The efforts from various institutes and governments for better funding toward research and treatment procedures support market growth. For instance, NINDS (National Institute of Neurological Disorders and Stroke) supports continuing initiatives to improve diagnostic standards for Traumatic Encephalopathy Syndrome and CTE (post-mortem diagnosis) (TES; diagnosis in the living). In addition, NINDS's TBI program supports and finances extramural researchers working on fundamental, clinical, and translational TBI studies. Investigations to comprehend the processes behind TBI and its consequences, as well as preclinical and clinical studies for diagnosis, prognosis, prospective treatments, and other TBI-related topics, are all financed by NINDS. An estimated dollar 192 million investment would be applied to TBI research by NINDS in 2023.Additionally, Dr. Barker, a TBI researcher who conducted a ground-breaking study on the biology of brain damage, has created cutting-edge new methods for detecting cognitive impairment. She was among the first to realize that more advanced neuropsychological tests may be created with today's technological advancements. She realized that modern computers had the opportunity to create automated testing that may quicken this procedure and created a simulation-based task test for cognitive impairment that is focused on cooking. The Cog-LAB cooking task (CT) prototype can simultaneously assess several facets of cognitive performance.
The rising attention toward providing guidelines for better treatment of TBI and the requirement for proper care positively impacted the market growth in recent years. For instance, the guidelines to properly ingest medication like, No large doses of lethal medications, disinhibition leading to suicides, the importance of complete therapeutic trials since under treatment is a common occurrence, minimizing benzodiazepines (impairing cognition), anticholinergics (induces sedation), seizure-inducing (impedes neuronal recovery), and antidopaminergic agents, no caffeine (disinhibiting), and to start low and go slow whenever medications are necessary (may precipitate aggression). Additionally, according to the CDC, there are several risks associated with TBI that it warns the population about. Like, TBI victims may experience health issues for a few days to the rest of their life, depending on the severity of the injury. For instance, a person with a minor traumatic brain injury (TBI) or concussion could suffer transient symptoms before feeling better within a few weeks or months.Additionally, a person with a moderate or severe TBI might have permanent repercussions from the damage. Children are more susceptible to TBI than adults are. Any damage to the growing brain might be fatal to adults and seniors.
The growth of the traumatic brain injury market is anticipated to be hampered by the crippling costs of treatment for traumatic brain injury treatment procedures, which populations cannot afford easily. Additionally, the need for proper treatment for traumatic brain injury due to the unavailability of technology to cross the blood-brain barrier, along with a stringent set of rules of TBI procedures and equipment set by the governments, are expected to hamper the market's growth.
The pandemic brought forth a situation of economic crisis worldwide. Several businesses were shut down due to insufficient transportation and consumers. The healthcare sector, however, became busier than ever as covid patients were continuously being rushed to hospitals leading to a shortage in supplies like beds and oxygen cylinders. All other medical emergencies were on hold, and the entire staff's attention was shifted toward COVID-19 care units. As the other healthcare cases were postponed, brain surgeries were put on hold, and the market saw a loss of revenue. However, several studies from different researchers pointed out that covid patients were experiencing neurological problems and that covid could be responsible for novel neurological disorders meaning the pandemic could have boosted the market. Therefore, the pandemic's impact on the market is mixed, resulting in positive and negative signs.
REPORT METRIC |
DETAILS |
Market Size Available |
2023 to 2029 |
Base Year |
2023 |
Forecast Period |
2024 to 2029 |
Segments Covered |
By Device, Technique, End User, and Region |
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
Regions Covered |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Market Leader profiled |
Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Nihon Kohden Corp., |
Based on the device, the imaging devices segment is expected to dominate the traumatic brain injury market during the forecast period due to the prominence of the sub-segments under imaging devices like X-rays, MRIs, CT scans, and others regularly used for diagnosing TBIs. However, the monitoring devices segment is also expected to show a healthy CAGR during the forecast period due to the need for continuous monitoring of patients with TBI to keep the brain's condition in check. In addition, it has been reported that many patients with TBI prefer non-invasive diagnostic procedures; therefore, 24/7 monitoring is crucial to meeting patients' needs.
Based on the technique, the intracranial pressure monitor segment is expected to dominate the market during the forecast period due to this technique's accuracy and everyday use to measure intracranial pressure in TBI patients. Additionally, ICP is a significant cause of death among patients; therefore, it is impertinent to measure the ICP for patient safety.However, the partial pressure of the oxygen segment is also expected to grow at a healthy CAGR during the forecast period as the techniques help to calculate the amounts of oxygen being transferred to the brain in TBI patients for effective diagnosis.
The hospital segment dominated the market in 2023 and is expected to grow at a healthy CAGR during the forecast period owing to the availability of advanced infrastructure and instruments, reputed neurological professionals, and a rapid influx of patients due to the credibility associated with hospital settings.However, the other segment, which includes the emergency clinics, research centers, ambulatory care services, etc., is expected to show a promising CAGR in the market due to their efficiency with work and lower medical costs along with immediate and fast treatment and recovery of patients.
The North American region accounted for most of the global market share in 2023. Rapid technological advancements, expanding government initiatives, an increasing number of people suffering from traumatic brain injuries, awareness campaigns about brain injuries, and well-established healthcare facilities are some key factors supporting the market in the North American region. In addition, an estimated 1,000,000 people suffer from a traumatic brain injury each year, accounting for 23,000 hospitalizations in the United States alone, and incidents of traffic accidents, injuries, permanent disabilities, and hospitalizations further accelerate the traumatic brain injury market this region.
However, the Europe and Asia-Pacific regions are also expected to show fast growth due to several factors, such as growth in the aging population, rising traffic accidents, and road injuries; for instance, 6,520 people were injured in road accidents in France in 2018. Additionally, the public appears to be highly interested in market innovations, increasing TBI patients, growing disposable incomes, growing patient affordability, lifestyle shift, and better healthcare facilities, key market players in countries like the U.K., France, Germany, China, India, South Korea, Japan, etc. are pushing the revenue for the regions.
The markets in Latin America, the Middle East, and Africa are also expected to grow during the forecast period. However, the market can face some restraints due to the region's lack of awareness and facilities.
Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Nihon Kohden Corp., Integra Lifesciences, and BioDirection, Inc. are a few of the noteworthy players in the global traumatic brain injury market and profiled in this report.
This market research report on the global traumatic brain injury market has been segmented and sub-segmented based on device, technique, end-user, and region.
By Device
By Technique
By End-Use
By Region
Frequently Asked Questions
The global traumatic brain injury market was worth USD 1.72 billion in 2023.
North America led the traumatic brain injury market worldwide in 2023.
Companies playing a notable role in the traumatic brain injury market are Compumedics Ltd., InfraScan, Inc., Oculogica, Raumedic AG, Nihon Kohden Corp., Integra Lifesciences and BioDirection, Inc.
The global traumatic brain injury market is anticipated to be growing at a CAGR of 9.12% from 2024 to 2029.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region